First new type of malaria treatment in decades shows promise against drug resistance
Promising results from a new malaria drug, ganaplacide–lumefantrine, offer hope against emerging drug resistance in Africa....
Promising results from a new malaria drug, ganaplacide–lumefantrine, offer hope against emerging drug resistance in Africa....
A new agreement between the University of Wisconsin School of Medicine and Public Health and NorthStar Medical Radioisotopes, LLC (NorthStar) is aimed at advancing research and supporting workforce development in the nuclear medicine sector....
A five-year, $12.5 million grant has been awarded to researchers at UW–Madison to investigate metastatic, or advanced stage, prostate cancer, the second most common cause of cancer death in men....
The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives....
GlobalData projects roughly 13% of trials remain undisclosed in early stages, meaning the overall volume is still underreported at the time of initiation....
Researchers around the globe are diligently working to improve access to early detection and treatment and reduce mortality through scientific breakthroughs....
The University of Wisconsin–Madison is partnering with Microsoft and TitletownTech on a new collaboration designed to accelerate scientific discovery through artificial intelligence. ...
The UW Health/SMPH Research Operations Committee's (UROC) 2026 submission and review schedule is now available....
A New Hampshire man is resuming dialysis after living with a gene-edited pig kidney for a record 271 days, doctors said Monday. His experience is helping researchers in their quest for animal-to-human transplants....
The first blood plasma test to identify hallmarks of Alzheimer’s disease was cleared in May by the U.S. Food and Drug Administration (FDA), and University of Wisconsin researchers provided a portion of the samples used in the clinical validation test....